Abstract:ObjectiveLocal production of estrogen via upregulated aromatase (CYP19, p450 arom) expression contributes to the persistence and self-propagation of endometriotic lesions. PPAR-γ ligands have been shown to decrease p450 arom in human granulosa cells. We sought to determine if a PPAR-γ ligand, ciglitazone (CIG), could affect aromatase expression in endometrial stromal cells.DesignIn vitro study using the human endometrial stromal cell line YHES.Materials and methodsExpression of PPAR-γ in YHES cells was demonstrated utilizing reverse transcriptase polymerase chain reaction (RT-PCR). YHES cells were plated and grown to confluence in 60 mm dishes × 48 hrs. Cells were then treated with IL-1β and/or CIG × 24 hrs. RNA isolation and extraction was performed. After total RNA was reverse transcribed to cDNA, real-time PCR was performed using the Real-Time 7300 System. Replicates consisted of: a) control (no IL-1β or CIG), b) IL-1β, c) CIG, and d) IL-1β + CIG. After treatment, real time-polymerase chain reaction was performed to quantify aromatase expression. Comparisons of aromatase expression between treatment groups were made using a one-way ANOVA with post hoc Bonferroni test.ResultsWe show the presence of PPAR-γ in YHES cells by RT-PCR. There was no difference in aromatase mRNA expression when the cells were treated with CIG alone. However, IL-1β (0.6 nM) increased aromatase expression by over 6-fold. When the YHES endometrial stromal cells were stimulated with IL-1β and CIG (40 μM), there was a statistically significant decrease in aromatase mRNA expression compared to IL-1β alone (P=0.026).ConclusionsCIG treatment significantly decreased aromatase expression in IL-1β-treated endometrial stromal cell line that harbors PPAR-γ. The downregulation of local aromatase production via PPAR-γ activation may facilitate regression of endometriotic lesions in patients with established disease. Hence, thiazolidinediones such as rosiglitazone may prove to be a useful treatment option for endometriosis-related pain and/or infertility. ObjectiveLocal production of estrogen via upregulated aromatase (CYP19, p450 arom) expression contributes to the persistence and self-propagation of endometriotic lesions. PPAR-γ ligands have been shown to decrease p450 arom in human granulosa cells. We sought to determine if a PPAR-γ ligand, ciglitazone (CIG), could affect aromatase expression in endometrial stromal cells. Local production of estrogen via upregulated aromatase (CYP19, p450 arom) expression contributes to the persistence and self-propagation of endometriotic lesions. PPAR-γ ligands have been shown to decrease p450 arom in human granulosa cells. We sought to determine if a PPAR-γ ligand, ciglitazone (CIG), could affect aromatase expression in endometrial stromal cells. DesignIn vitro study using the human endometrial stromal cell line YHES. In vitro study using the human endometrial stromal cell line YHES. Materials and methodsExpression of PPAR-γ in YHES cells was demonstrated utilizing reverse transcriptase polymerase chain reaction (RT-PCR). YHES cells were plated and grown to confluence in 60 mm dishes × 48 hrs. Cells were then treated with IL-1β and/or CIG × 24 hrs. RNA isolation and extraction was performed. After total RNA was reverse transcribed to cDNA, real-time PCR was performed using the Real-Time 7300 System. Replicates consisted of: a) control (no IL-1β or CIG), b) IL-1β, c) CIG, and d) IL-1β + CIG. After treatment, real time-polymerase chain reaction was performed to quantify aromatase expression. Comparisons of aromatase expression between treatment groups were made using a one-way ANOVA with post hoc Bonferroni test. Expression of PPAR-γ in YHES cells was demonstrated utilizing reverse transcriptase polymerase chain reaction (RT-PCR). YHES cells were plated and grown to confluence in 60 mm dishes × 48 hrs. Cells were then treated with IL-1β and/or CIG × 24 hrs. RNA isolation and extraction was performed. After total RNA was reverse transcribed to cDNA, real-time PCR was performed using the Real-Time 7300 System. Replicates consisted of: a) control (no IL-1β or CIG), b) IL-1β, c) CIG, and d) IL-1β + CIG. After treatment, real time-polymerase chain reaction was performed to quantify aromatase expression. Comparisons of aromatase expression between treatment groups were made using a one-way ANOVA with post hoc Bonferroni test. ResultsWe show the presence of PPAR-γ in YHES cells by RT-PCR. There was no difference in aromatase mRNA expression when the cells were treated with CIG alone. However, IL-1β (0.6 nM) increased aromatase expression by over 6-fold. When the YHES endometrial stromal cells were stimulated with IL-1β and CIG (40 μM), there was a statistically significant decrease in aromatase mRNA expression compared to IL-1β alone (P=0.026). We show the presence of PPAR-γ in YHES cells by RT-PCR. There was no difference in aromatase mRNA expression when the cells were treated with CIG alone. However, IL-1β (0.6 nM) increased aromatase expression by over 6-fold. When the YHES endometrial stromal cells were stimulated with IL-1β and CIG (40 μM), there was a statistically significant decrease in aromatase mRNA expression compared to IL-1β alone (P=0.026). ConclusionsCIG treatment significantly decreased aromatase expression in IL-1β-treated endometrial stromal cell line that harbors PPAR-γ. The downregulation of local aromatase production via PPAR-γ activation may facilitate regression of endometriotic lesions in patients with established disease. Hence, thiazolidinediones such as rosiglitazone may prove to be a useful treatment option for endometriosis-related pain and/or infertility. CIG treatment significantly decreased aromatase expression in IL-1β-treated endometrial stromal cell line that harbors PPAR-γ. The downregulation of local aromatase production via PPAR-γ activation may facilitate regression of endometriotic lesions in patients with established disease. Hence, thiazolidinediones such as rosiglitazone may prove to be a useful treatment option for endometriosis-related pain and/or infertility.

PPAR-gamma Inhibits Endometrial Stromal Cell Transcription and Translation of RANTES in Vitro

[Effects of PRL-3 Sirna on the Migration of Endometriotic Stromal Cells].

Human Endometrial Stromal Cell Differentiation is Stimulated by PPARβ/δ Activation: New Targets for Infertility?

Pigment Epithelium Derived Factor Inhibits the Growth of Human Endometrial Implants in Nude Mice and of Ovarian Endometriotic Stromal Cells in Vitro

C-Jun Nh2-Terminal Kinase and P38 Inhibition Suppresses Prostaglandin E2-Stimulated Aromatase and Estrogen Receptor Levels in Human Endometriosis

Chronic Medroxyprogesterone Acetate (mpa) Treatment of Human Endometrial Stromal Cells Inhibits Chemokine Gene Expression.

Effect of Progesterone on the Expression of HOXA11 Gene in Cultured Human Endometrial Glandular Epithelial Cells

[Effects of Parthenolide on Estradiol-Synthesizing Enzyme, ER Isoforms and VEGF in Human Endometriotic Stromal Cells].

Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells

Peroxisome proliferator-activated receptor-gamma and retinoid X receptor agonists synergistically suppress proliferation of immortalized endometrial stromal cells.

PPARβ/δ ligands regulate the expression of immune response mediators in the porcine endometrium - An in vitro study

Effect of PPAR Ligands on Extracellular Matrix Metalloproteinase Inducer Expression in Macrophages and Foam Cells

Effect of 17#Beta#--estradiol on Secretion of the Chemokines IL--8,MIP--1#alpha#,RANTES and I--309 by Endometrial Stromal Cells in Vitro

Effect of 17β-estradiol on secretion of the chemokines IL-8,MIP-1α,RANTES and I-309 by endometrial stromal cells in vitro

Functional Study of Progesterone Receptor Isoforms in Endometrial Cancer Cell Lines

Estrogen Receptor Β Agonist Diarylpropionitrile Inhibits Lipopolysaccharide-Induced Regulated on Activation Normal T Cell Expressed and Secreted (RANTES) Production in Macrophages by Repressing Nuclear Factor Κb Activation.

Increased Expression of TGF-β1 Contributes to the Downregulation of Progesterone Receptor Expression in the Eutopic Endometrium of Infertile Women with Minimal/Mild Endometriosis

Effect of Regulating Peroxisome Proliferator-Activated Receptor Γ on Soluble Endoglin Expression in First-Trimester Trophoblasts

Epithelial-Stromal Interactions Induce Rantes Expression in Endometriosis.

[Effect of Endothelin-1 Stimulation on Peroxisome Proliferator-Activated Receptor-Gamma Expression in Vascular Smooth Muscle Cells].

PPAR-gamma Ligand Activation Decreases Aromatase Expression in Endometrial Stromal Cells